Your browser doesn't support javascript.
loading
High-dose, weekly erlotinib is not an effective treatment in EGFR-mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinib.
Kuiper, J L; Heideman, D A M; Thunnissen, E; van Wijk, A W; Postmus, P E; Smit, E F.
Afiliação
  • Kuiper JL; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: jl.kuiper@vumc.nl.
  • Heideman DA; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
  • Thunnissen E; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
  • van Wijk AW; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.
  • Postmus PE; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.
  • Smit EF; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.
Eur J Cancer ; 50(7): 1399-401, 2014 May.
Article em En | MEDLINE | ID: mdl-24582911
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Receptores ErbB / Neoplasias Pulmonares / Neoplasias Meníngeas / Antineoplásicos Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinazolinas / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Receptores ErbB / Neoplasias Pulmonares / Neoplasias Meníngeas / Antineoplásicos Idioma: En Ano de publicação: 2014 Tipo de documento: Article